Medestea Internazionale

Medestea Internazionale is an Italian healthcare company based in Turin that specializes in the research, development, and commercialization of nutraceuticals, cosmeceuticals, and medical devices. The company achieved international prominence through its innovative research into microcirculation and adipose tissue metabolism, leading to the creation of the flagship anti-cellulite brand, Cellulase. Medestea operates with a strong focus on evidence-based wellness, utilizing a proprietary approach termed Physiological Modulation to develop products for dermatology, urology, and aesthetic medicine. While the company divested several of its major over-the-counter brands to Omega Pharma (now Perrigo) in 2009, it continues to be a leader in specialized health sectors and maintains an active R&D pipeline. Its portfolio includes well-known products such as Prostafactors for prostate health and Krestina for hair care.